Prima BioMed is a biotechnology company developing personalized bio-therapeutic products for cancer in Australia. The company’s lead product is CVac™, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients in remission and soon to be in trials for additional cancer types. In addition, PBMD focuses on developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. For more information visit the company’s Web site at www.primabiomed.com.au
Let us hear your thoughts below: